Stock Incentives (Tables)

12 Months Ended

Jul. 01, 2018

Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]

Schedule of Assumptions Used to Determine Fair Value

The assumptions used to determine fair value are as follows:

Options Granted During	2018			2017			2016
Grant Date Fair Value	$	4.64		$	3.84		$	3.72
(Since options are only granted once per year, the grant date fair value equals the weighted average grant date fair value.)
Assumptions:
Risk-free Interest Rate	1.8		%	1.2		%	1.7		%
Expected Volatility	30.7		%	29.3		%	25.1		%
Expected Dividend Yield	2.7		%	2.9		%	2.5		%
Expected Term (in Years)	5.5			5.5			5.5

Schedule of Options Outstanding

Information on the options outstanding is as follows:

	Options		Wtd. Avg. Exercise Price		Wtd. Avg. Remaining Contractual Term (in years)	Aggregate Intrinsic Value (in thousands)
Balance, June 28, 2015	2,176,850		$	18.86
Granted During the Year	501,990		19.90
Exercised During the Year	(697,309	)	17.77
Expired During the Year	(136,988	)	19.88
Balance, July 3, 2016	1,844,543		$	19.48
Granted During the Year	496,880		19.15
Exercised During the Year	(414,176	)	18.76
Balance, July 2, 2017	1,927,247		$	19.55
Granted During the Year	416,210		20.47
Exercised During the Year	(184,530	)	20.44
Balance, July 1, 2018	2,158,927		$	19.64	6.90	$	—
Exercisable, July 1, 2018	743,847		$	19.37	4.65	$	—

Schedule of Options Grants Outstanding Summary

Options Outstanding (as of July 1, 2018)
Fiscal Year	Grant Date	Date Exercisable	Expiration Date	Exercise Price		Options Outstanding
2014	8/20/2013	8/20/2016	8/31/2018	$	20.82	200,327
2015	10/21/2014	10/21/2017	10/21/2024	$	18.83	543,520
2016	8/18/2015	8/18/2018	8/18/2025	$	19.90	501,990
2017	8/22/2016	8/22/2019	8/22/2026	$	19.15	496,880
2018	8/21/2017	8/21/2020	8/21/2027	$	20.47	416,210

Summary of Nonvested Shares

Below is a summary of the status of the Company’s nonvested shares as of July 1, 2018, and changes during the year then ended:

	Deferred Stock / RSU				Restricted Stock				Stock Options				Performance Shares
	Shares		Wtd. Avg. Grant Date Fair Value		Shares		Wtd. Avg. Grant Date Fair Value		Shares		Wtd. Avg. Grant Date Fair Value		Shares		Wtd. Avg. Grant Date Fair Value
Nonvested shares/units, July 2, 2017	105,974		$	19.32	699,635		$	19.47	1,556,040		$	3.79	220,381		$	19.48
Granted	13,476		20.39		148,930		20.52		416,210		4.64		—		21.19
Cancelled	(3,989	)	20.47		(11,940	)	19.51		—		—		—		—
Vested	(36,640	)	19.15		(141,370	)	18.83		(557,170	)	3.81		(113,941	)	19.29
Nonvested shares/units, July 1, 2018	78,821		$	19.52	695,255		$	19.87	1,415,080		$	4.03	106,440		$	19.90

Schedule of Stock-Based Compensation Programs

The following table summarizes the components of the Company’s stock-based compensation programs recorded as expense:

	2018			2017			2016
Stock Options:
Pretax compensation expense	$	2,060		$	1,862		$	1,763
Tax benefit	(576		)	(698		)	(661		)
Stock option expense, net of tax	$	1,484		$	1,164		$	1,102
Restricted Stock:
Pretax compensation expense	$	3,302		$	3,291		$	2,750
Tax benefit	(924		)	(1,234		)	(1,031		)
Restricted stock expense, net of tax	$	2,378		$	2,057		$	1,719
Deferred Stock:
Pretax compensation expense	$	1,046		$	585		$	102
Tax benefit	(292		)	(220		)	(38		)
Deferred stock expense, net of tax	$	754		$	365		$	64
Performance Shares:
Pretax compensation expense	$	267		$	(815	)	$	494
Tax expense (benefit)	(75		)	306			(185		)
Performance Share expense, net of tax	$	192		$	(509	)	$	309
Total Stock-Based Compensation:
Pretax compensation expense	$	6,675		$	4,923		$	5,109
Tax benefit	(1,867		)	(1,846		)	(1,915		)
Total stock-based compensation, net of tax	$	4,808		$	3,077		$	3,194